cbdMD (YCBD) EPS (Basic) Growth (3y) (2019 - 2026)
cbdMD (YCBD) EPS (Basic) Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 15.17% |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 3.18% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 2.42% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 12.25% |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -35.06% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 13.47% |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 36.60% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | cbdMD | 5.41 Mn | 3.29 Mn | 3.04 Mn | 77.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 77.03% |
| Dec 31, 2025 | 89.32% |
| Sep 30, 2025 | 87.85% |
| Jun 30, 2025 | 89.76% |
| Mar 31, 2025 | 61.95% |
| Dec 31, 2024 | 76.02% |
| Sep 30, 2024 | 57.83% |
| Jun 30, 2024 | -29.94% |
| Mar 31, 2024 | 50.25% |
| Dec 31, 2023 | 56.51% |
| Sep 30, 2023 | -8.78% |
| Jun 30, 2023 | 47.26% |
| Mar 31, 2023 | -27.96% |
| Dec 31, 2022 | -29.60% |
| Sep 30, 2022 | -34.24% |
| Jun 30, 2022 | 22.77% |
| Mar 31, 2022 | 68.70% |
| Dec 31, 2021 | -18.43% |
| Sep 30, 2021 | 11.60% |
| Jun 30, 2021 | -12.26% |